Formulation and devices for monitoring the efficacy of the delivery of aerosols

• US 20010010223A1
• Filed: 02/26/2001
• Published: 08/02/2001
• Est. Priority Date: 02/24/1997
• Status: Active Grant

• Current Assignee: Aradigm Corporation
• Original Assignee: Aradigm Corporation
• Inventors: Gonda, Igor
• Granted Patent: US 6,349,719 B2
• Time in Patent Office: Days
• US Class Current: 128/200.14
• CPC Class Codes: A61M 15/00 Inhalators drug delivery in endotracheal tubes A61M16/04
• CPC Class Codes: A61M 15/003 using capsules, e.g. to be perforated or broken-up
• CPC Class Codes: A61M 15/0043 Non-destructive separation of the package, e.g. peeling
• CPC Class Codes: A61M 2205/6081 Colour codes

Abstract

Aerosolizable formulations are disclosed comprised of a pharmaceutically acceptable carrier, a pharmaceutically active drug or detectably labeled compound and a compound which is recognized by its distinct color, taste and/or smell even when present in a small amount and a low concentration. Examples of such compounds include menthol, peppermint, cinnamon and vanilla flavors and water soluble dyes. The compounds can be designed so that they are only detectable by a specific area of the tongue or seen under a certain wavelength of light. The degree of detection of the color, taste or smell of the compound is an indication of the degree of success in the delivery of an aerosolized formulation to a patient. The formulation is preferably delivered from a device which monitors and records information relating to the patient'"'"'s respiratory movement and also scans and analyzes the aerosol prior to inhalation. The device sends the user a visual and/or audible signal which informs the user about the character of the aerosol formed. By means of the taste and smell as well as the signal obtained from the device the user is provided with multiple indications of the efficacy of the aerosolized dose delivered.

Claims

1. An aerosol formulation;

comprising;

a pharmaceutically acceptable carrier;

an active compound selected from the group consisting of a pharmaceutically active drug and a detectably labeled compound; and

a sensory compound with a characteristic selected from the group consisting of a distinctive color, a distinctive taste and a distinctive smell.

2. The aerosol formulation of

claim 1

, wherein the sensory compound has a distinctive taste.

3. The aerosol formulation of

claim 1

, wherein the sensory compound is selected from the group consisting of menthol, peppermint, cinnamon and vanilla.

4. The formulation of

claim 1

, wherein the active compound is a pharmaceutically active drug and the carrier is water.

5. The formulation of

claim 1

, wherein the sensory compound has a distinctive color.

6. The formulation of

claim 1

, wherein the active compound is a pharmaceutically active compound and the sensory compound has a distinctive taste and color.

7. The formulation of

claim 6

, wherein the taste is distinctly sweet, sour, bitter or salty and the color contrasts with the color of the inside of a human mouth.

8. An aerosolized mist of particles wherein 25% or more of the particles have a diameter in the range of from about 0.5 micron to about 10 microns, the particles comprising:

a pharmaceutically acceptable carrier;

an active compound selected from the group consisting of pharmaceutically active drug and a detectably labeled compound; and

a sensory compound with a characteristic selected from the group consisting of a distinctive color, a distinctive taste and a distinctive smell.

9. The aerosolized mist of

claim 8

, wherein 25% or more of the particles have a diameter in the range of about 1 to about 3 microns.

10. The aerosol formulation of

claim 8

, wherein the sensory compound has a distinctive taste.

11. The aerosol formulation of

claim 8

, wherein the sensory compound is selected from the group consisting of menthol, peppermint, cinnamon and vanilla.

12. The aerosol formulation of

claim 8

, wherein the sensory compound has a distinctive color.

13. The aerosol formulation of

claim 12

, wherein the color is from a water soluble dye which dye has a color selected from the group consisting of blue, green and purple.

14. A method of monitoring aerosol delivery efficacy, comprising:

creating an aerosolized mist of particles 25% or more of which having a diameter in the range of from about 1 micron to about 8 microns, the particles comprising;

a pharmaceutically acceptable carrier, an active compound selected from the group consisting of pharmaceutically active drug and a radioactive labeled compound, and a sensory compound with a characteristic selected from the group consisting of a distinctive color, a distinctive taste and a distinctive smell;

inhaling the aerosolized mist through the mouth and into the lungs; and

analyzing delivery efficacy to the lungs based on detected color, taste or smell.

15. The method of

claim 14

, further comprising:

scanning the aerosolized mist with light;

analyzing the aerosolized mist based on the scan; and

providing a user with results of the analysis.

16. A method of monitoring aerosol delivery efficacy, comprising:

creating an aerosolized mist of particles having a diameter in the range of 1 micron to 8 microns wherein the particles comprise a pharmaceutically active drug;

scanning the mist with a light source of a detector;

determining a percentage of particles within a given size range parameter; and

signaling;

a user when the determined percentage of particles fall outside of the given size range.

17. The method of

claim 16

, wherein the given size range is 0.5 to 6.0 microns in diameter.

18. The method of

claim 16

, wherein the particle are further comprised of a sensory compound.

19. The method of

claim 18

, wherein the sensory compound has a distinctive taste and a distinctive color.

20. The method of

claim 16

, wherein the particles are further comprised of a radioactive label.